Osteoclasts are essential for TNF-alpha-mediated joint destruction
- PMID: 12438440
- PMCID: PMC151809
- DOI: 10.1172/JCI15582
Osteoclasts are essential for TNF-alpha-mediated joint destruction
Abstract
The detailed cellular and molecular mechanisms leading to joint destruction in rheumatoid arthritis, a disease driven by proinflammatory cytokines, are still unknown. To address the question of whether osteoclasts play a pivotal role in this process, transgenic mice that express human TNF (hTNFtg) and that develop a severe and destructive arthritis were crossed with osteopetrotic, c-fos-deficient mice (c-fos(-/-)) completely lacking osteoclasts. The resulting mutant mice (c-fos(-/-)hTNFtg) developed a TNF-dependent arthritis in the absence of osteoclasts. All clinical features of arthritis, such as paw swelling and reduction of grip strength, progressed equally in both groups. Histological evaluation of joint sections revealed no difference in the extent of synovial inflammation, its cellular composition (except for the lack of osteoclasts), and the expression of matrix metalloprotein-ase-3 (MMP-3) and MMP-13. In addition, cartilage damage, proteoglycan loss, and MMP-3, -9, and -13 expression in chondrocytes were similar in hTNFtg and c-fos(-/-)hTNFtg mice. However, despite the presence of severe inflammatory changes, c-fos(-/-)hTNFtg mice were fully protected against bone destruction. These data reveal that TNF-dependent bone erosion is mediated by osteoclasts and that the absence of osteoclasts alters TNF-mediated arthritis from a destructive to a nondestructive arthritis. Therefore, in addition to the use of anti-inflammatory therapies, osteoclast inhibition could be beneficial for the treatment of rheumatoid arthritis.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/151809/bin/JCI0215582.f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/151809/bin/JCI0215582.f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/151809/bin/JCI0215582.f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/151809/bin/JCI0215582.f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/151809/bin/JCI0215582.f5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/151809/bin/JCI0215582.f6.gif)
Similar articles
-
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.Arthritis Rheum. 2004 Jan;50(1):277-90. doi: 10.1002/art.11487. Arthritis Rheum. 2004. PMID: 14730626
-
JNK1 is not essential for TNF-mediated joint disease.Arthritis Res Ther. 2005;7(1):R166-73. doi: 10.1186/ar1473. Epub 2004 Dec 7. Arthritis Res Ther. 2005. PMID: 15642137 Free PMC article.
-
RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.J Bone Miner Res. 2004 Feb;19(2):207-13. doi: 10.1359/JBMR.0301233. J Bone Miner Res. 2004. PMID: 14969390
-
Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates.Best Pract Res Clin Rheumatol. 2005 Dec;19(6):1065-79. doi: 10.1016/j.berh.2005.06.008. Best Pract Res Clin Rheumatol. 2005. PMID: 16301197 Review.
-
[Mechanism of the bone destruction in rheumatoid arthritis].Nihon Rinsho. 2005 Sep;63(9):1571-3. Nihon Rinsho. 2005. PMID: 16164213 Review. Japanese.
Cited by
-
Screening of Diagnostic Biomarkers and Immune Infiltration Characteristics Linking Rheumatoid Arthritis and Rosacea Based on Bioinformatics Analysis.J Inflamm Res. 2024 Aug 1;17:5177-5195. doi: 10.2147/JIR.S467760. eCollection 2024. J Inflamm Res. 2024. PMID: 39104909 Free PMC article.
-
Vigeo attenuates cartilage and bone destruction in a collagen‑induced arthritis mouse model by reducing production of pro‑inflammatory cytokines.Exp Ther Med. 2024 Mar 19;27(5):208. doi: 10.3892/etm.2024.12496. eCollection 2024 May. Exp Ther Med. 2024. PMID: 38590570 Free PMC article.
-
Osteoimmunology: The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis.Int J Mol Sci. 2024 Feb 26;25(5):2688. doi: 10.3390/ijms25052688. Int J Mol Sci. 2024. PMID: 38473934 Free PMC article. Review.
-
Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets.Mol Med. 2024 Feb 3;30(1):20. doi: 10.1186/s10020-024-00788-w. Mol Med. 2024. PMID: 38310228 Free PMC article. Review.
-
RhoA Promotes Synovial Proliferation and Bone Erosion in Rheumatoid Arthritis through Wnt/PCP Pathway.Mediators Inflamm. 2023 Nov 1;2023:5057009. doi: 10.1155/2023/5057009. eCollection 2023. Mediators Inflamm. 2023. PMID: 38022686 Free PMC article.
References
-
- Scott DL, et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology. 2000;39:122–132. - PubMed
-
- Sack U, et al. Systemic characteristics of chronic arthritis induced by transfer of human rheumatoid synovial membrane into SCID mice (human/murine SCID arthritis) J Autoimmun. 1999;13:335–346. - PubMed
-
- Okada Y, et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest. 1995;72:311–322. - PubMed
-
- van Meurs J, et al. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity. Arthritis Rheum. 1999;42:2074–2084. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous